Synovus to participate at Barclays Global Financial Services Conference
Synovus to participate at Barclays Global Financial Services Conference
Synovus Financial Corp. (NYSE: SNV) Chairman, CEO and President Kevin Blair and Executive Vice President and Chief Financial Officer Jamie Gregory will participate in a fireside chat at the Barclays 22nd Annual Global Financial Services Conference in New York City on Sept. 9, 2024, at 3:30 p.m. ET.
A live webcast and replay will be available at https://investor.synovus.com/events.
Synovus Financial Corp. is a financial services company based in Columbus, Georgia, with approximately $60 billion in assets. Synovus provides commercial and consumer banking and a full suite of specialized products and services, including private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets and international banking. Synovus has branches in Georgia, Alabama, South Carolina, Florida and Tennessee. Synovus is a Great Place to Work-Certified Company. Learn more about Synovus at synovus.com.
Media Contact
Audria Belton
Media Relations
media@synovus.com
Investor Contact
Jennifer H. Demba, CFA
Investor Relations
investorrelations@synovus.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240819389160/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks